News

Eveliqure Biotechnologies announced the publication of preclinical data with ShigETEC, its vaccine candidate against Shigellae and Enterotoxic E. coli…

Read more

Valneva today announced that it will convene an Extraordinary General Meeting (EGM) to be held on December 22, 2020.

Read more

Read more

A new method developed by researchers of the Vienna BioCenter, SARSeq, will allow testing of thousands of samples for SARS-CoV-2 and other pathogens…

Read more

Valneva reported today its nine-month financial results ending September 30, 2020.

Q3 milestones included

  • Major COVID-19 vaccine partnership with…
Read more

Researchers from the laboratory of Jürgen Knoblich at IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – developed…

Read more

 

Transmembrane Transport Proteins (TMTs) control nutrient uptake, ion transport, and drug transport across biological membranes.

Read more

Scientists from the Vienna BioCenter developed a new SARS-CoV-2 detection method: by rather simple means, their RT-LAMP test is cheaper than PCR…

Read more

Valneva today announced that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation for its single-shot Phase 3…

Read more

Viruses depend on their hosts to copy themselves and spread. Upon infection, a virus will hijack the host machinery to replicate its genome,…

Read more

The 2020 Nobel Prize for Chemistry is awarded to Emmanuelle Charpentier and Jennifer Doudna for their groundbreaking discoveries on the CRISPR/Cas9…

Read more

OpGen announced that its subsidiary Ares Genetics has won the Austrian Digitization Award.

Read more

In a project supported by the Volkswagen foundation, the lab of Bojan Zagrovic and their collaborators Zoya Ignatova (University of Hamburg) and…

Read more